Archive

Health Canada approves COVID 19 AstraZeneca vaccine to prevent COVID-19

Written by Charlie King | 17 Mar 2021

Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19) and a related shot by the Serum Institute of India for use in Canada.

The pathological development of rheumatoid arthritis

Written by Christine Clark | 17 Mar 2021

Interview and article by Christine Clark. Recent research into the molecular basis for rheumatoid arthritis may be pointing the way to targeted therapy to prevent inflammation and joint… read more.

Five day treatment of pediatric pneumonia is as effective as longer treatment

Written by Bruce Sylvester | 17 Mar 2021

Article by Bruce Sylvester. Treatment of common pneumonia in children six months to 10 years-old with a five-day course of high-dose amoxicillin is as effective as 10-day treatment,… read more.

Update on the safety of COVID-19 Vaccine AstraZeneca

Written by Charlie King | 16 Mar 2021

Following a recent concern raised around thrombotic events, AstraZeneca would like to offer its reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence. Safety… read more.

Green tea lowers mortality among stroke survivors

Written by Bruce Sylvester | 16 Mar 2021

Article written by Bruce Sylvester. Daily consumption of green tea lowers the risk of death among stroke survivors, Japanese researchers reported on Feb. 4, 2021 in the journal… read more.

FDA approves Azstarys to treat attention deficit hyperactivity disorder – Kem Pharma Inc

Written by Charlie King | 15 Mar 2021

KemPharm, Inc. has announced that the FDA has approved the New Drug Application for Azstarys (formerly referred to as KP 415), a once-daily product for the treatment of… read more.

Statins not linked to muscle pain

Written by Bruce Sylvester | 15 Mar 2021

Article written by Bruce Sylvester British researchers report finding no link between statin therapy and muscle pain. The findings appeared on Feb.28, 2021 in the BMJ/British Medical Journal.

GW Pharmaceuticals receives positive CHMP opinion for Epidyolex for use as treatment of seizures associated with tuberous sclerosis complex

Written by Charlie King | 14 Mar 2021

GW Pharmaceuticals plc , a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines, announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for… read more.

EMA backs six new medicines

Written by Gary Finnegan | 14 Mar 2021

Article written by Gary Finnegan. The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting:

FDA approves Yescarta to treat relapsed or refractory follicular lymphoma after two lines of systemic therapy – Kite/Gilead Sciences

Written by Charlie King | 13 Mar 2021

Kite, a Gilead Company announced that the FDA has granted accelerated approval to Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory follicular lymphoma… read more.

International agencies coordinate regulation of COVID-19 vaccines and medicines

Written by Gary Finnegan | 13 Mar 2021

Article written by Gary Finnegan. Regulators around the globe are aligning their approaches to the approval of vaccines and medicines against COVID-19. Closer cooperation is seen as crucial… read more.

FDA expands approval of Lorbrena as first line treatment of metastatic NSCLC – Pfizer

Written by Charlie King | 12 Mar 2021

The FDA approved Pfizer Inc.’s supplemental New Drug Application (sNDA) for Lorbrena (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small… read more.

« Previous 1 … 51 52 53 54 55 … 63 Next »

Archive

Subscribe for our mailing list

Follow Us